Q-Line Biotech (NSE:QLINE) Total Assets: ₹4,555 Mil (As of Mar. 2025)


NSE:QLINE Q-Line Biotech Ltd NSE:QLINE
12 GF Score
Price ₹546.50
! 2 Warning Signs
View Full Analysis

What is Q-Line Biotech Total Assets?

Q-Line Biotech NSE:QLINE -5.15% 12 Total Assets is ₹4,555 Mil as of Mar. 2025. GuruFocus rates NSE:QLINE with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Q-Line Biotech's Total Assets for the quarter that ended in Mar. 2025 was ₹4,555 Mil.

During the past 12 months, Q-Line Biotech's average Total Assets Growth Rate was 34.50% per year.

Total Assets is connected with ROA %. Q-Line Biotech's annualized ROA % for the quarter that ended in Mar. 2025 was 7.08%. Total Assets is also linked to Revenue through Asset Turnover. Q-Line Biotech's Asset Turnover for the quarter that ended in Mar. 2025 was 0.79.

Q-Line Biotech  (NSE:QLINE) Total Assets Explanation

Total Assets is connected with ROA %.

Q-Line Biotech's annualized ROA % for the quarter that ended in Mar. 2025 is

ROA %=Net Income (Q: Mar. 2025 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=281.309/( (3392.46+4554.859)/ 2 )
=281.309/3973.6595
=7.08 %

Note: The Net Income data used here is one times the annual (Mar. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Q-Line Biotech's Asset Turnover for the quarter that ended in Mar. 2025 is

Asset Turnover
=Revenue (Q: Mar. 2025 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=3137.804/( (3392.46+4554.859)/ 2 )
=3137.804/3973.6595
=0.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Q-Line Biotech Total Assets Related Terms

Q-Line Biotech Total Assets Historical Data

* Premium members only.

The historical data trend for Q-Line Biotech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-Line Biotech Total Assets Chart

Q-Line Biotech Annual Data
Trend Mar23 Mar24 Mar25
Total Assets
2,515.80 3,392.46 4,554.86

Q-Line Biotech Semi-Annual Data
Mar23 Mar24 Mar25
Total Assets 2,515.80 3,392.46 4,554.86
NSE:QLINE
12GF Score
Q-Line Biotech Ltd NSE:QLINE
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-Line Biotech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Q-Line Biotech's Total Assets for the fiscal year that ended in Mar. 2025 is calculated as

Total Assets=Total Equity (A: Mar. 2025 )+Total Liabilities (A: Mar. 2025 )
=1899.453+2655.406
=4,555

Q-Line Biotech's Total Assets for the quarter that ended in Mar. 2025 is calculated as

Total Assets=Total Equity (Q: Mar. 2025 )+Total Liabilities (Q: Mar. 2025 )
=1899.453+2655.406
=4,555

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of ₹4,555 Mil mean?
Q-Line Biotech (NSE:QLINE) has a Total Assets of ₹4,555 Mil as of Mar. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Q-Line Biotech and its competitors.
Is Q-Line Biotech's Total Assets too high?
Q-Line Biotech's current Total Assets is ₹4,555 Mil. Overall, Q-Line Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Q-Line Biotech's Total Assets compare to ABT and SYK?
Q-Line Biotech's Total Assets of ₹4,555 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Q-Line Biotech and its competitors. Q-Line Biotech's current Total Assets is ₹4,555 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-Line Biotech stock overvalued right now?
Q-Line Biotech (NSE:QLINE) has a current Total Assets of ₹4,555 Mil. The current Total Assets is ₹4,555 Mil. Q-Line Biotech's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Q-Line Biotech (NSE:QLINE), the current Total Assets is ₹4,555 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Q-Line Biotech Business Description

Address Kanpur Road Adjacent Transport Nagar Metro Station, 298-281, Transport Nagar, Lucknow, UP, IND, 226012
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. It is engaged in Manufacturing and Trading into Biochemistry Regnant, Instruments and Consumables. The majority of revenue is derived from the Manufacturing segment.
12GF Score

Get the complete analysis for NSE:QLINE

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹546.50
Price